Checkpoint Therapeutics I...
(CKPT) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
3.52
-3.29%
After-hours Jan 03, 2025, 04:35 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Revenue | 103.00K | 192.00K | 268.00K | 1.07M | 1.71M | 3.51M | 1.73M | 2.57M | 590.00K |
Cost of Revenue | 43.57M | 49.83M | 48.45M | 16.35M | 19.32M | 33.65M | 19.08M | 20.27M | 11.32M |
Gross Profit | -43.46M | -49.63M | -48.19M | -15.28M | -17.62M | -30.15M | -17.36M | -17.70M | -10.73M |
Operating Income | -52.15M | -58.33M | -56.72M | -23.20M | -24.85M | -36.74M | -22.77M | -22.16M | -13.22M |
Interest Income | 84.00K | 160.00K | 53.00K | 120.00K | 136.00K | 148.00K | 98.00K | 47.00K | 2.00K |
Pretax Income | -51.85M | -62.62M | -56.67M | -23.08M | -24.71M | -36.37M | -22.68M | -22.46M | -13.89M |
Net Income | -51.85M | -66.92M | -56.62M | -22.96M | -24.58M | -36.37M | -22.68M | -22.46M | -13.89M |
Selling & General & Admin | 8.69M | 8.70M | 8.54M | 7.92M | 7.23M | 6.59M | 5.42M | 4.47M | 2.49M |
Research & Development | 43.57M | 49.83M | 48.45M | 16.35M | 19.32M | 33.65M | 19.08M | 20.27M | 11.32M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 225.00K | n/a | n/a | n/a |
Operating Expenses | 52.25M | 58.52M | 56.99M | 24.27M | 26.56M | 40.25M | 24.50M | 24.73M | 13.81M |
Interest Expense | n/a | 4.29M | n/a | n/a | n/a | n/a | n/a | 344.00K | 235.00K |
Selling & Marketing Expenses | n/a | 400.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 52.25M | 58.52M | 56.99M | 24.27M | 26.56M | 40.25M | 24.50M | 24.73M | 13.81M |
Income Tax | n/a | 4.29M | -53.00K | -120.00K | -136.00K | -521.00K | -22.68M | -22.12M | 233.00K |
Shares Outstanding (Basic) | 18.74M | 8.84M | 7.60M | 5.58M | 3.53M | 2.86M | 2.26M | 2.15M | 2.44M |
Shares Outstanding (Diluted) | 18.74M | 8.84M | 7.60M | 5.58M | 3.53M | 2.86M | 2.26M | 2.15M | 2.44M |
EPS (Basic) | -2.77 | -7.57 | -7.45 | -4.11 | -6.96 | -12.74 | -10.03 | -10.43 | -5.69 |
EPS (Diluted) | -2.77 | -7.57 | -7.45 | -4.11 | -6.96 | -12.74 | -10.03 | -10.43 | -5.69 |
EBITDA | -52.15M | -58.33M | -56.72M | -23.20M | -24.85M | -36.74M | -22.68M | -22.12M | -13.22M |
Depreciation & Amortization | n/a | 4.45M | 236.56K | 206.30K | 171.86K | 36.74M | 22.77M | 22.16M | 2.00K |